FDA inspection
Nephron Sterile Compounding Center LLC: FDA inspection ending Aug 28, 2006
FDA inspection 439600 · Voluntary Action Indicated (VAI) · West Columbia, SC
Key facts
| Inspection ID | 439600 |
|---|---|
| Firm | Nephron Sterile Compounding Center LLC |
| FEI number | 3011158388 |
| Address | 4500 12th Street Ext |
| City | West Columbia |
| State | SC |
| ZIP | 29172-3025 |
| Fiscal year | 2006 |
| Inspection end date | Aug 28, 2006 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data